Seth Forster

Company: Merck

Job title: Associate Principal Scientist, Discovery Pharmaceutical Sciences

Seminars:

Formulation Strategies for Long-Acting Injectable Prodrugs in Schizophrenia: Reducing Dosing Burden 9:30 am

Designing prodrugs for extended CNS exposure: How modulation of physicochemical properties supports monthly or longer dosing for conditions like schizophrenia Overcoming high-load suspension issues, selecting excipients, and optimizing vehicles for improved injectability and stability Trends toward patient-centric administration (e.g., subcutaneous), potential for at-home use, and innovations in drug-device combinations Approaches to modulating physicochemical properties (e.g.,…Read more

day: Day One - Morning